Dordea Matei, Moore U, Batty J, Lennard T W J, Aspinall S R
Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, Tyne and Wear, NE1 4LP, UK.
Northumbria Healthcare NHS Foundation Trust, Rake Lane, North Shields, NE29 8NH, UK.
Langenbecks Arch Surg. 2018 Nov;403(7):897-903. doi: 10.1007/s00423-018-1714-x. Epub 2018 Oct 20.
Ultrasound localisation of parathyroid glands correlates with gland weight. We hypothesise that gland identification is also dependent on anatomical location. Perrier et al. have described a uniform and reliable nomenclature for parathyroid locations. We aimed to correlate surgeon-performed ultrasound (SUS) with intra-operative Perrier classification and gland weight.
Review of a prospectively maintained single operator SUS database of 194 patients referred with non-familial primary hyperparathyroidism (PHPT) at a tertiary centre between 2010 and 2015. Patients underwent MIBI localisation as well as on table SUS. Intra-operative pathological gland locations were classified according to the Perrier nomenclature.
Mean weight of pathological glands found and missed by SUS was 1.07 ± 0.1 g and 0.48 ± 0.08 g respectively (p = 0.0001, unpaired t test). The weight of glands identified was greater than that of missed glands for each of the Perrier locations (p < 0.001, Mann-Whitney). The proportion of pathological glands found at each Perrier location varied significantly (p < 0.0001, Chi Square); so we find proportionally more B-, D-, E- and F-type glands and miss more A- and C-type glands. The median weight of glands missed on SUS varied significantly across the Perrier groups (Kruskal-Wallis, p = 0.0034) and suggests that SUS can miss quite large glands (> 0.5 g) in locations B, C and F; whereas missed glands in locations A, D and E were all small (< 0.5 g).
Whilst gland identification correlates well with gland weight, anatomical location has a significant impact on failure of localisation irrespective of gland weight. For the surgeon operating on PHPT patients with negative US localisation, particular attention should be paid to locations C, D and A as these are the sites where pathological glands are most often missed on pre-operative US.
甲状旁腺的超声定位与腺体重量相关。我们推测腺体的识别也取决于解剖位置。佩里尔等人已经描述了一种统一且可靠的甲状旁腺位置命名法。我们旨在将外科医生进行的超声检查(SUS)与术中的佩里尔分类及腺体重量进行关联。
回顾一个前瞻性维护的单操作者SUS数据库,该数据库包含2010年至2015年间在一家三级中心因非家族性原发性甲状旁腺功能亢进症(PHPT)就诊的194例患者。患者接受了甲氧基异丁基异腈(MIBI)定位以及术中SUS检查。术中病理腺体位置根据佩里尔命名法进行分类。
SUS检查发现和漏诊的病理腺体平均重量分别为1.07±0.1克和0.48±0.08克(p = 0.0001,独立样本t检验)。在佩里尔分类的每个位置,识别出的腺体重量均大于漏诊腺体的重量(p < 0.001,曼-惠特尼检验)。在每个佩里尔位置发现的病理腺体比例差异显著(p < 0.0001,卡方检验);因此,我们发现B、D、E和F型腺体的比例相对较高,而漏诊的A和C型腺体较多。SUS漏诊的腺体中位重量在佩里尔各组间差异显著(克鲁斯卡尔-沃利斯检验,p = 0.0034),这表明SUS在B、C和F位置可能漏诊相当大的腺体(>0.5克);而在A、D和E位置漏诊的腺体都较小(<0.5克)。
虽然腺体识别与腺体重量密切相关,但解剖位置对定位失败有显著影响,无论腺体重量如何。对于对超声定位阴性的PHPT患者进行手术的外科医生,应特别关注C、D和A位置,因为这些是术前超声最常漏诊病理腺体的部位。